117632-35-6

Basic information

• Product Name: 3-Furancarboxylicacid,tetrahydro-2-methoxy-,methylester,trans-(9CI)
• Synonyms: 3-Furancarboxylicacid,tetrahydro-2-methoxy-,methylester,trans-(9CI)
• CAS NO: 117632-35-6
• Molecular Formula: C7H12O4
• Molecular Weight: 0
• Product Categories: CARBOXYLICESTER
• Mol File: 117632-35-6.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Furancarboxylicacid,tetrahydro-2-methoxy-,methylester,trans-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Furancarboxylicacid,tetrahydro-2-methoxy-,methylester,trans-(9CI)(117632-35-6)
• EPA Substance Registry System: 3-Furancarboxylicacid,tetrahydro-2-methoxy-,methylester,trans-(9CI)(117632-35-6)

Safety Data

• Hazardous Substances Data: 117632-35-6(Hazardous Substances Data)

Upstream product

• 96-48-0 4-butanolide 
• 109-94-4 formic acid ethyl ester 
• 67-56-1 methanol 
• 107-31-3 Methyl formate 
• 61541-20-6 methyl 4-hydroxy-2-methylenebutanoate 
• 83124-80-5 3-trichloroacetyl-4,5-dihydrofuran 
• 7647-01-0 hydrogenchloride 
• 53855-26-8 2-formyl-γ-butyrolactone 
• 127915-15-5 2-oxotetrahydrofuran-3-carboxylic acid methyl ester 

Downstream Products

• 1708-33-4 4-hydroxy-butyraldehyde-(2,4-dinitro-phenylhydrazone) 
• 65038-86-0 4,5-dihydro-furan-3-carboxylic acid p-toluidide 
• 206860-63-1 C₁₇H₂₇Cl₂N₂O₄P 

Relevant articles and documents

HETEROCYCLIC AMIDES AS ROCK INHIBITORS

The present invention relates to new kinase inhibitors of formula (I), more specifically ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In particular, the present invention relates to new ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In addition, the invention relates to methods of treatment and use of said compounds in the manufacture of a medicament for the application to a number of therapeutic indications including sexual dysfunction, inflammatory diseases, ophthalmic diseases and Respiratory diseases.

New strategy for the diastereoselective synthesis of bicyclic 'pre- activated' analogues of cyclophosphamide

The diastereoselective synthesis of 'pro-activated' analogues of cyclophosphamide in the 3-[bis(2-chloroethyl)amino]-2-aza-4,9-dioxa-3- phosphabicyclo(4.3.0)nonane 3-oxide series is described, using either the phosphorylation of an azidoalcohol followed by a reductive cyclisation or the phosphorylation of an acetal alcohol followed by an unprecedent direct Lewis acid catalyzed intramolecular substitution.

Haloacetylated Enol Ethers: 4. Synthesis of 4-Trihalomethyl-2-methylthiopyrimidines

The synthesis of a series of 5- and 6-substituted 4-trihalomethyl-2-methylthiopyrimidines, prepared from the cyclocondensation reaction of β-alkoxyvinyl trichloromethyl ketones with 2-methyl-2-thiopseudourea sulfate, are reported.A systematic study to find the best reation conditions werre carried out.

Palladium(II)-Catalyzed Diastereoselective Acetalization of Hydroxyalkenes

Pd(II)-Catalyzed cyclization of methyl (2S,3S)-2-allyl-3-hydroxybutyrate with methanol gives (2R,4S,5S)-2,5-dimethyl-2-methoxy-4-methoxycarbonyltetrahydrofuran in 88percent de.The cyclization of (2R,3S)-2-allyl-1,3-butandiol gives homochiral bicyclic acetal 3 (R1 = Me).

STEREOSELECTIVE SYNTHESES OF 2-SUBSTITUTED PERHYDROFUROFURANS

New reagents for the stereoselective synthesis of 2-substituted perhydrofurofurans are described.In the successful approach towards the latter compounds, the key steps were the addition of a monolithio-2α-methoxy-3β-perhydrofuran to an aldehyde and a dilithio-2α-methoxy-3β-perhydrofuran to a carboxyl derivative, respectively.The structures and conformations of the 2-tert-butyl- and 2-isopropylperhydrofurofurans were examined by means of (1)H-NMR double resonance and the 2D-NOE spectroscopy.